Centrient Pharmaceuticals, which seeks to use “green technology” to make generic antibiotics and other drugs, has slapped Dalas Biotech with a lawsuit accusing the Indian company of patent infringement involving its amoxicillin trihydrate API.
In its lawsuit filed in the Delhi High Court, Centrient’s Indian subsidiary, Centrient Pharmaceuticals Private Ltd., asked for a permanent...






